CareDx, Inc. Share Price Today: Live Updates & Key Insights

CareDx, Inc. share price today is $17.28, up -2.5%. The stock opened at $17.46 against the previous close of $17.59, with an intraday high of $17.76 and low of $17.01.

CareDx, Inc. Share Price Chart

CareDx, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

CareDx, Inc. Share Price Performance

$17.28 -0.025(-2.5%) CDNA at 23 Mar 2026 12:24 PM Diagnostics & Research
Lowest Today 17.01
Highest Today 17.76
Today’s Open 17.46
Prev. Close 17.59
52 Week High 21.49
52 Week Low 10.96
Day’s Range: Low 17.01 High 17.76
52-Week Range: Low 10.96 High 21.49
1 day return -
1 Week return -0.98
1 month return -8.52
3 month return -14.23
6 month return +14.46
1 year return -12.44
3 year return +93.57
5 year return -75.4
10 year return -

CareDx, Inc. Institutional Holdings

BlackRock Inc 9.31

Vanguard Group Inc 6.69

BAMCO Inc 6.16

State Street Corp 5.01

Baron Discovery Institutional 4.43

Baron Discovery Strategy 4.43

Deerfield Management Co 4.28

ARK Genomic Revolution ETF 4.24

ARK Investment Management LLC 4.17

ARK Genomic Revolution 3.99

Gagnon Securities LLC 3.47

Sumitomo Mitsui Trust Group Inc 3.40

BRAIDWELL LP 3.10

Vanguard Total Stock Mkt Idx Inv 3.00

State Street® SPDR® S&P® Biotech ETF 2.96

Amova Asset Management Americas, Inc 2.82

Dimensional Fund Advisors, Inc. 2.56

iShares Russell 2000 ETF 2.49

Geode Capital Management, LLC 2.43

Amova ARK Pstv Chg Innovt P JPY Acc 2.18

Renaissance Technologies Corp 2.16

Chevy Chase Trust Holdings, Inc. 2.11

D. E. Shaw & Co LP 2.03

Jacobs Levy Equity Management, Inc. 1.85

Ophir Asset Management Pty Ltd 1.81

Boston Partners Global Investors, Inc 1.76

The Goldman Sachs Group Inc 1.68

Portolan Capital Management, LLC 1.48

Vanguard Institutional Extnd Mkt Idx Tr 1.08

Fidelity Small Cap Index 1.00

First Eagle Small Cap Opportunity I 0.90

JNL Multi-Manager Small Cap Growth A 0.88

First Eagle US Small Cap Strategy 0.88

iShares Russell 2000 Growth ETF 0.85

Nuveen Quant Small Cap Equity R6 0.71

ArrowMark Small Cap Gro 0.68

Meridian Small Cap Growth Legacy 0.68

iShares Biotechnology ETF 0.68

Column Small Cap Select 0.60

State St Russell Sm/Mid Cp® Indx SL Cl I 0.59

CareDx, Inc. Market Status

Strong Buy: 4

Buy: 1

Hold: 3

Sell: 0

Strong Sell: 0

CareDx, Inc. Fundamentals

Market Cap 882.07 M

PB Ratio 2.8979

PE Ratio 0.0

Enterprise Value 727.35 M

Total Assets 413.23 M

Volume 1041625

CareDx, Inc. Company Financials

Annual Revenue FY25:379805000 379.8M, FY24:333785000 333.8M, FY23:297139000 297.1M, FY22:321793000 321.8M, FY21:296397000 296.4M

Annual Profit FY25:null 0.0M, FY24:333785000 333.8M, FY23:191263000 191.3M, FY22:209581000 209.6M, FY21:199008000 199.0M

Annual Net worth FY25:-21354000 -21.4M, FY24:52549000 52.5M, FY23:-90516000 -90.5M, FY22:-76613000 -76.6M, FY21:-30662000 -30.7M

Quarterly Revenue Q4/2025:108386000 108.4M, Q3/2025:100055000 100.1M, Q2/2025:86679000 86.7M, Q1/2025:84685000 84.7M, Q4/2024:86579000 86.6M

Quarterly Profit Q4/2025:null 0.0M, Q3/2025:68746000 68.7M, Q2/2025:58021000 58.0M, Q1/2025:56270000 56.3M, Q4/2024:86579000 86.6M

Quarterly Net worth Q4/2025:-4109000 -4.1M, Q3/2025:1675000 1.7M, Q2/2025:-8568000 -8.6M, Q1/2025:-10353000 -10.4M, Q4/2024:87697000 87.7M

About CareDx, Inc. & investment objective

Company Information CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; and AlloHeme, a monitoring test that predicts relapse in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, the company provides QTYPE that enables precision in human leukocyte antigen (HLA) typing; Olerup SSP, which is used to type HLA alleles based on sequence specific primer technology; and Ottr, a transplant patient management software. Further, it offers AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a solution that monitors the pharmacokinetics of engraftment and persistence of cells for patients who have received allogeneic cell therapy; and XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems software solutions. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.

Organisation Diagnostics & Research

Employees 761

Industry Diagnostics & Research

CEO Mr. John Walter Hanna Jr.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CareDx, Inc. FAQs

What is the share price of CareDx, Inc. today?

The current share price of CareDx, Inc. is $17.28.

Can I buy CareDx, Inc. shares in India?

Yes, Indian investors can buy CareDx, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy CareDx, Inc. shares in India?

You can easily invest in CareDx, Inc. shares from India by:

Can I buy fractional shares of CareDx, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CareDx, Inc.?

CareDx, Inc. has a market cap of $882.07 M.

In which sector does CareDx, Inc. belong?

CareDx, Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in CareDx, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of CareDx, Inc.?

The PE ratio of CareDx, Inc. is N/A and the PB ratio is 2.90.